Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
- BIOLOGICAL: Prodencel; an autologous dendritic cell therapeutic tumor vaccine
Sponsor
Shanghai Humantech Biotechnology Co. Ltd
Collaborators